Tech Company Financing Transactions
Armata Pharmaceuticals Funding Round
On 3/4/2024, Armata Pharmaceuticals announced $35 million in funding from Innoviva.
Transaction Overview
Company Name
Announced On
3/4/2024
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds will be used to advance the Company's lead therapeutic phage candidates, including AP-PA02 and AP-SA02, which target infections caused by Pseudomonas aeruginosa and Staphylococcus aureus, respectively.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4503 Glencoe Avenue
Marina del Rey,, CA 90292
USA
Marina del Rey,, CA 90292
USA
Phone
Website
Email Address
Overview
A Purposeful, Precise and Powerful Approach to Address the Global Antibiotic Resistance Crisis. Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections. Antibiotic overuse has led to the marked rise of multidrug-resistant bacteria, putting us on the verge of a post-antibiotic era in which common infections can be serious or life-threatening. Additionally, the use of broad-spectrum antibiotics is known for disrupting the ecology of the human microbiome, leading to disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Varnum
Chief Medical Officer
Mina Pastagia
VP - Finance
Erin Butler
VP - Operations
Duane Morris
Browse more venture capital transactions:
Prev: 3/4/2024: Baseten venture capital transaction
Next: 3/4/2024: BBT.live venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs